Ligand Pharmaceuticals Inc. (LGND)
Market Closed
17 Jul, 20:00
$
303. 39
+6.94
+2.341%
$
6.03B Market Cap
23.93 P/E Ratio
- Div Yield
278,300 Volume
4.45 Eps
$ 296.45
Previous Close 
Want to track LGND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ligand Pharmaceuticals Inc. (LGND) Statistics
Valuation metrics
Market Cap 6.03B
Enterprise value 6.42B
Trailing P/E (ttm) 38.7
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 22.15
Price/Book (mrq) 6.05
Enterprise Value/Revenue 23.38
Enterprise Value/EBITDA 28.88
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 340.56K
Average volume (90 days) 236.41K
Price summary
52-Week low 129.47
52-Week high 326.63
Beta -
50-Day moving average 288.63
200-Day moving average 210.71
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 19 Apr 2007
Ex-Dividend Date 3 Apr 2007
Last split factor 1,603:1,000
Last split Date 2 Nov 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.56%
Operating margin 0.37%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.16%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 13.8
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 7.72
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 39.2
Total debt (mrq) -
Total Debt/Equity (mrq) 0.45
Current ratio (mrq) 21.28%
Book value per share (mrq) 50.16
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
